GE HealthCare Technologies Inc. logo GEHC - GE HealthCare Technologies Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 10
HOLD 8
SELL 0
STRONG
SELL 0
| PRICE TARGET: $83.27 DETAILS
HIGH: $105.00
LOW: $65.00
MEDIAN: $85.00
CONSENSUS: $83.27
UPSIDE: 29.64%
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue
Revenue 20,625 19,672 19,552 18,341 17,585 17,164 16,633
Cost of Revenue 12,378 11,467 11,630 11,162 10,411 10,397 10,085
Gross Profit 8,247 8,205 7,922 7,179 7,174 6,767 6,548
Operating Expenses
R&D Expenses 1,260 1,311 1,205 1,026 816 810 833
SG&A Expenses 4,225 4,269 4,282 3,631 3,563 3,237 3,591
Other Expenses 0 0 0 0 0 0 0
Operating Expenses 5,485 5,580 5,487 4,657 4,379 4,047 4,424
Operating Income
Operating Income 2,762 2,625 2,435 2,522 2,795 2,720 2,124
Interest Expense 450 505 542 86 40 66 88
Interest Income 0 0 26 0 34 49 36
Profitability
EBITDA 3,785 3,666 3,513 3,165 3,540 3,406 2,838
EBIT 3,207 3,086 2,903 2,532 2,915 2,776 2,179
Income Before Tax 2,768 2,581 2,361 2,512 2,875 2,710 2,091
Income Tax Expense 614 531 743 563 600 652 410
Net Income 2,084 1,993 1,568 1,916 2,247 13,846 1,524
Per Share Data
EPS (Basic) 4.56 4.37 3.04 4.22 4.90 4.41 3.35
EPS (Diluted) 4.55 4.34 3.02 4.22 4.90 4.41 3.35
Shares Outstanding 456.5 456 455 453.9 454.7 454.7 454.7
Metric 2025 2024 2023 2022 2021 2020
Current Assets
Cash & Cash Equivalents 4,512 2,890 2,504 1,445 556 1,007
Short-Term Investments 0 0 0 0 0 0
Net Receivables 3,955 4,376 4,315 3,993 3,791 2,657
Inventory 2,234 1,939 1,960 2,155 1,946 1,594
Other Current Assets 0 311 231 226 250 190
Total Current Assets 10,701 9,516 9,010 7,819 6,543 5,448
Non-Current Assets
Property, Plant & Equipment 3,092 2,550 2,500 2,314 2,235 2,202
Goodwill 13,489 13,136 12,936 12,813 12,892 11,868
Intangible Assets 1,130 1,078 1,253 1,520 1,847 1,603
Long-Term Investments 0 804 733 663 665 709
Other Non-Current Assets 0 1,531 1,548 860 839 909
Total Non-Current Assets 22,202 23,573 23,444 19,720 19,765 18,780
Total Assets 36,906 33,089 32,454 27,539 26,308 24,228
Current Liabilities
Account Payables 3,250 3,022 2,947 3,090 2,729 2,387
Short-Term Debt 508 1,502 1,116 119 110 132
Deferred Revenue 0 1,943 1,918 1,896 1,864 1,813
Other Current Liabilities 5,347 1,450 1,482 1,233 1,174 1,269
Total Current Liabilities 9,105 9,553 8,981 7,191 6,761 6,524
Non-Current Liabilities
Long-Term Debt 9,495 7,449 8,436 8,234 31 31
Deferred Tax Liabilities 193 56 68 370 385 459
Other Non-Current Liabilities 7,514 6,382 6,643 1,240 1,307 1,366
Total Non-Current Liabilities 17,202 14,883 16,163 10,756 2,651 2,730
Total Liabilities 26,307 24,436 25,144 17,947 9,412 9,254
Stockholders' Equity
Common Stock 5 5 5 0 0 0
Retained Earnings 5,281 3,262 1,326 0 0 0
Accumulated Other Comprehensive Income (1,388) (1,379) (691) 9,357 16,655 14,727
Total Stockholders' Equity 10,379 8,447 7,133 9,357 16,655 14,727
Total Liabilities & Equity 36,906 33,089 32,454 27,539 26,308 24,228
Debt Metrics
Total Debt 10,003 9,376 9,863 8,635 437 468
Net Debt 5,491 6,486 7,359 7,190 (119) (539)
Metric 2025 2024 2023 2022 2021 2020 2019
Operating Activities
Net Income 2,154 2,050 1,618 1,949 2,275 2,058 1,681
Depreciation & Amortization 578 580 610 633 625 630 659
Stock-Based Compensation 130 125 114 67 76 0 0
Change in Working Capital (357) (59) 22 (293) (1,370) (52) (387)
Other Non-Cash Items (517) (1,276) (1,006) (806) (599) (1,601) (374)
Operating Cash Flow 1,988 1,951 2,101 2,113 1,607 1,687 1,989
Investing Activities
Capital Expenditure (482) (401) (387) (310) (248) (259) (331)
Acquisitions 0 (313) (147) 0 (1,481) (78) 0
Purchases of Investments (118) (40) (48) (59) 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0
Other Investing Activities (447) (160) 24 (29) (32) 20,301 (62)
Investing Cash Flow (1,047) (914) (558) (398) (1,761) 19,986 (325)
Financing Activities
Net Debt Issuance 967 (423) 1,139 8,204 (12) (16) (59)
Stock Repurchased (200) 0 0 0 0 0 0
Dividends Paid (64) (55) (41) 0 0 0 0
Other Financing Activities (123) (128) (1,576) (9,026) (251) (21,528) (1,515)
Financing Cash Flow 617 (573) (478) (822) (263) (21,544) (1,574)
Cash Position
Net Change in Cash 1,622 387 1,055 890 (451) 143 35
Cash at Beginning 2,893 2,506 1,451 561 1,012 869 834
Cash at End 4,515 2,893 2,506 1,451 561 1,012 869
Free Cash Flow 1,506 1,550 1,714 1,803 1,359 1,428 1,658
Key Metrics 2025 2024 2023 2022 2021 2020 2019
Income Statement
Revenue 20,625 19,672 19,552 18,341 17,585 17,164 16,633
Gross Profit 8,247 8,205 7,922 7,179 7,174 6,767 6,548
Operating Income 2,762 2,625 2,435 2,522 2,795 2,720 2,124
Net Income 2,084 1,993 1,568 1,916 2,247 13,846 1,524
EPS (Diluted) 4.55 4.34 3.02 4.22 4.90 4.41 3.35
Balance Sheet
Cash & Equivalents 4,512 2,890 2,504 1,445 556 1,007
Total Assets 36,906 33,089 32,454 27,539 26,308 24,228
Total Debt 10,003 9,376 9,863 8,635 437 468
Stockholders' Equity 10,379 8,447 7,133 9,357 16,655 14,727
Cash Flow
Operating Cash Flow 1,988 1,951 2,101 2,113 1,607 1,687 1,989
Capital Expenditure (482) (401) (387) (310) (248) (259) (331)
Free Cash Flow 1,506 1,550 1,714 1,803 1,359 1,428 1,658